GlaxoSmithKline

Prescription for success: Emma Walmsley leads GSK transformation

After spending a decade lagging behind its peers, GSK named a new CEO in 2017. Despite having minimal experience in drug development, Emma Walmsley may well have turned out to be the lifeline the company needed

29 Nov 2018

GlaxoSmithKline (GSK) announced that it has bought out Novartis’ stake in their joint consumer healthcare venture. GSK will now own 100 percent of the business

GlaxoSmithKline buys out Novartis’ stake in joint venture

$13bn acquisition will give GlaxoSmithKline full ownership of the over-the-counter healthcare business

27 Mar 2018

Emma Walmsley becomes first female CEO of GlaxoSmithKline

Consumer goods specialist Emma Walmsley will succeed Andrew Witty as the head of GlaxoSmithKline – the UK’s biggest pharmaceutical group

20 Sep 2016

GlaxoSmithKline CEO Sir Andrew Witty to resign

Sir Andrew Neil, the CEO of GlaxoSmithKline, has announced his intention to resign in March 2017, having served the company for eight years

17 Mar 2016

Awards Supplement 2019

The European CEO awards 2019 have now been announced, presenting our pick of the CEOs, companies and campaigns leading their sectors.